“The attempt by large pharmaceutical companies to form a consortium to produce integrated data sets failed”

Kenneth Oye, Political Scientist at the Massachusetts Institute of Technology. “Regulators should not require superior efficacy as a criterion for granting a licence to a drug. By approving equally ef...

This content is for subscribers only
Subscribe now and get access to all content, exclusive newsletters and daily analysis.

Most read